research Alopecia Areata in 12 years old female treated with Oral Azathioprine: A case report and review
Azathioprine may help treat Alopecia Areata.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research The efficacy and safety of tofacitinib in patients with alopecia totalis
Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.
research Updated diagnostic criteria for frontal fibrosing alopecia
New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.
research Acitretin-Altered Squamous Cell Carcinoma
research Health‐related quality of life (hrQoL ) among patients with primary cicatricial alopecia (PCA ): A systematic review
Primary cicatricial alopecia significantly reduces life quality, mainly due to pain and anxiety.
research Dermoscopic And Clinical Features Of Alopecia Areata In Pakistani Patients: A Cross-Sectional Study
Alopecia Areata affects both genders almost equally, mostly on the scalp, with common signs like yellow dots and exclamation mark hairs, especially in young people.
research Use of rotary echoes in 2 H
A new method accurately measures molecular movement without complex modeling.
research Awareness, Beliefs, and Psychological Impact of Patients with Alopecia Areata in Saudi Arabia: A Multi-Center Study
Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.
research A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.
research PD02-05 SRD5A2 EXPRESSION IS A PREDICTOR OF RESPONSE TO FINASTERIDE IN THE MTOPS TRIAL
Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.